IN2014DN05786A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DN05786A IN2014DN05786A IN5786DEN2014A IN2014DN05786A IN 2014DN05786 A IN2014DN05786 A IN 2014DN05786A IN 5786DEN2014 A IN5786DEN2014 A IN 5786DEN2014A IN 2014DN05786 A IN2014DN05786 A IN 2014DN05786A
- Authority
- IN
- India
- Prior art keywords
- maillard reaction
- beverage
- living body
- food
- reaction inhibitor
- Prior art date
Links
- 239000002683 reaction inhibitor Substances 0.000 abstract 5
- 235000013361 beverage Nutrition 0.000 abstract 4
- 208000002249 Diabetes Complications Diseases 0.000 abstract 2
- 206010012655 Diabetic complications Diseases 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 102000008186 Collagen Human genes 0.000 abstract 1
- 108010035532 Collagen Proteins 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 230000032683 aging Effects 0.000 abstract 1
- 230000003712 anti-aging effect Effects 0.000 abstract 1
- 230000003178 anti-diabetic effect Effects 0.000 abstract 1
- 239000003472 antidiabetic agent Substances 0.000 abstract 1
- 229920001436 collagen Polymers 0.000 abstract 1
- 230000006866 deterioration Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000008442 polyphenolic compounds Chemical class 0.000 abstract 1
- 235000013824 polyphenols Nutrition 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 235000018553 tannin Nutrition 0.000 abstract 1
- 229920001864 tannin Polymers 0.000 abstract 1
- 239000001648 tannin Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/66—Proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
- A23L3/3472—Compounds of undetermined constitution obtained from animals or plants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
- A23L5/27—Removal of unwanted matter, e.g. deodorisation or detoxification by chemical treatment, by adsorption or by absorption
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Botany (AREA)
- Birds (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Biochemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
Abstract
Provided are: a Maillard reaction inhibitor which can inhibit the progress of a Maillard reaction in a living body effectively does not cause any adverse side effect can be applied safely and can be produced without requiring any complicated process; and an anti aging agent for skin an anti diabetic complication agent a food and a beverage in each of which the Maillard reaction inhibitor is used. The Maillard reaction inhibitor according to the present invention contains 50 to 90 mass% of a polyphenol as an active ingredient. The Maillard reaction inhibitor according to the present invention has a potent inhibitory activity on a Maillard reaction and therefore can inhibit a Maillard reaction in a living body efficiently and can prevent and improve various functional disorders of proteins occurring in a living body. Due to this activity the Maillard reaction inhibitor can prevent aging and is useful for the prevention and treatment of diabetic complications. When the tannin is added to a collagen containing food or beverage the occurrence of a Maillard reaction in the food or beverage can be prevented to thereby prevent the deterioration of the food or beverage and the occurrence of a Maillard reaction in a living body can also be prevented.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011285694 | 2011-12-27 | ||
PCT/JP2012/083992 WO2013100105A1 (en) | 2011-12-27 | 2012-12-27 | Maillard reaction inhibitor |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014DN05786A true IN2014DN05786A (en) | 2015-05-15 |
Family
ID=48697583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN5786DEN2014 IN2014DN05786A (en) | 2011-12-27 | 2012-12-27 |
Country Status (14)
Country | Link |
---|---|
US (2) | US20140349953A1 (en) |
EP (1) | EP2799075A4 (en) |
JP (2) | JP5441232B2 (en) |
KR (1) | KR20140107614A (en) |
CN (1) | CN104114176A (en) |
AU (1) | AU2012361496A1 (en) |
BR (1) | BR112014015928A8 (en) |
CA (1) | CA2861745A1 (en) |
HK (1) | HK1199823A1 (en) |
IN (1) | IN2014DN05786A (en) |
PH (1) | PH12014501485A1 (en) |
RU (1) | RU2014131057A (en) |
SG (1) | SG11201403628SA (en) |
WO (1) | WO2013100105A1 (en) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2014042261A1 (en) * | 2012-09-13 | 2016-08-18 | 森下仁丹株式会社 | Sirtuin gene activity enhancer and pharmaceuticals, cosmetics and foods using the same |
CN104341461B (en) * | 2014-10-28 | 2017-08-29 | 河南中烟工业有限责任公司 | Cigarette monomer perfume Mal Thr, preparation method and applications |
CN104341465B (en) * | 2014-10-28 | 2017-08-29 | 河南中烟工业有限责任公司 | Hydrophilic fragrance-enhancing tobacco humectant Mal Ala, preparation method and applications |
CN104341464A (en) * | 2014-10-28 | 2015-02-11 | 河南中烟工业有限责任公司 | Hydrophilic tobacco aroma enhancing humectant Mal-Gly as well as preparation method and application thereof |
CN104341462B (en) * | 2014-10-28 | 2017-08-29 | 河南中烟工业有限责任公司 | Sugar derivatives cigarette flavouring humectant Mal Trp, preparation method and applications |
CN104356174A (en) * | 2014-10-28 | 2015-02-18 | 河南中烟工业有限责任公司 | Monomer spice Mal-Phe for tobacco as well as preparation method and application of monomer spice |
CN104341466B (en) * | 2014-10-28 | 2017-08-29 | 河南中烟工业有限责任公司 | Cigarette monomer perfume Mal Val, preparation method and applications |
CN104341463B (en) * | 2014-10-28 | 2017-08-29 | 河南中烟工业有限责任公司 | Cigarette monomer perfume Mal Ile, preparation method and applications |
CN104341467A (en) * | 2014-10-28 | 2015-02-11 | 河南中烟工业有限责任公司 | Monomer flavor Mal-Amb used for cigarettes as well as preparation method and application thereof |
CN104370979A (en) * | 2014-10-28 | 2015-02-25 | 河南中烟工业有限责任公司 | Cigarette monomer spice Mal-Ser as well as preparation method and application thereof |
US20170368018A1 (en) * | 2014-12-19 | 2017-12-28 | Halo Life Science, Llc | Use of ellagic acid dihydrate in pharmaceutical formulations to regulate blood glucose levels |
US20170367390A1 (en) * | 2014-12-19 | 2017-12-28 | Halo Life Science, Llc | Use of ellagic acid dihydrate in food products and nutraceuticals |
MX2017010215A (en) * | 2015-02-09 | 2017-11-17 | Procter & Gamble | Cleaning and/or treatment compositions. |
KR101552813B1 (en) * | 2015-05-18 | 2015-09-11 | 충남대학교산학협력단 | Compositions for preventing or treating benign prostatic hyperplasia comprising extracts of Quisqualis indica |
JP6586337B2 (en) * | 2015-09-29 | 2019-10-02 | 株式会社ノエビア | Beverage |
CN106620746B (en) * | 2015-11-02 | 2019-06-14 | 中国石油化工股份有限公司 | A method of it reducing Maillard reaction and microorganism growth and fermentation inhibitory is acted on |
CN106620745B (en) * | 2015-11-02 | 2019-10-11 | 中国石油化工股份有限公司 | A kind of method of Maillard reaction during reduction medium sterilization |
JP6673864B2 (en) * | 2016-06-30 | 2020-03-25 | 林兼産業株式会社 | Advanced saccharification product formation inhibitor |
WO2018125931A1 (en) | 2016-12-30 | 2018-07-05 | Abbott Laboratories | Nutritional compositions with protein, beta-hydroxy-beta-methylbutyrate (hmb), and fiber |
US12036311B2 (en) | 2018-05-30 | 2024-07-16 | Mitsui Sugar Co., Ltd. | Anti-obesity agent, anti-dementia agent, deodorant, anti-aging agent, anti-glycation agent, anti-type I allergy agent, hypotensive agent, flavor improving agent, muscle enhancing agent, and bone metabolism improving agent |
WO2019230907A1 (en) * | 2018-05-30 | 2019-12-05 | 三井製糖株式会社 | Anti-obesity agent, anti-dementia agent, deodorant, anti-aging agent, anti-glycation agent, anti-type i allergy agent, hypotensive agent, flavor improving agent, muscle enhancing agent, and bone metabolism improving agent |
JP7512008B2 (en) * | 2018-05-30 | 2024-07-08 | Dm三井製糖株式会社 | Anti-glycation agents |
CN109619208A (en) * | 2019-02-13 | 2019-04-16 | 黑龙江八农垦大学 | A kind of imitative meat product and its processing method enhancing flavor |
CN111007135B (en) * | 2019-12-25 | 2022-08-02 | 广东食品药品职业学院 | Method for evaluating anti-saccharification effect of plant extract |
FR3109301B1 (en) * | 2020-04-17 | 2022-05-06 | Soc Ind Limousine Dapplication Biologique | ACTIVE INGREDIENT COMPRISING A PARTICULAR PUNICA GRANATUM EXTRACT AND USES FOR PREVENTING AND/OR FIGHTING ACNE |
CN114712384B (en) * | 2022-04-11 | 2023-05-16 | 湖北工业大学 | Application of chitosan EGCG composition in inhibiting formation of gastrointestinal cross-linking agent |
CN115024357A (en) * | 2022-06-20 | 2022-09-09 | 东北农业大学 | Method for inhibiting generation of advanced glycosylation end products in frozen chicken meatballs |
CN115646392A (en) * | 2022-11-03 | 2023-01-31 | 江西中烟工业有限责任公司 | Preparation method and application of Maillard reaction product containing polyphenol |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000143491A (en) * | 1998-11-06 | 2000-05-23 | Pola Chem Ind Inc | Cosmetic for caring aging |
US7611738B2 (en) * | 2005-05-24 | 2009-11-03 | Pom Wonderful, Llc | Processes for extracting phytochemicals from pomegranate solids and compositions and methods of use thereof |
JP2002241299A (en) | 2001-02-13 | 2002-08-28 | Ichimaru Pharcos Co Ltd | Maillard reaction recovering agent |
JP4195840B2 (en) | 2003-07-18 | 2008-12-17 | アークレイ株式会社 | Maillard reaction inhibitor |
JP4897229B2 (en) * | 2005-03-15 | 2012-03-14 | 学校法人 関西大学 | Maillard reaction inhibitor |
JP2008214250A (en) | 2007-03-02 | 2008-09-18 | Hokkaido Mitsui Chemicals Inc | Maillard reaction inhibitor |
EP2190445B1 (en) * | 2007-07-27 | 2017-07-19 | The State Of Israel-Ministry Of Agriculture & Rural Development | Pomegranate sprouts, preparations derived therefrom and compositions comprising same |
BR112012002183A2 (en) * | 2009-07-24 | 2016-05-31 | Amazentis Sa | compounds, compositions and methods to protect brain health in neurodegenerative disorders |
JP2011102270A (en) | 2009-11-11 | 2011-05-26 | Rohto Pharmaceutical Co Ltd | Anti-saccharification agent |
JP5719581B2 (en) * | 2010-12-10 | 2015-05-20 | 丸善製薬株式会社 | Anti-glycation agent |
JP2013103930A (en) * | 2011-11-16 | 2013-05-30 | Koei Kogyo Kk | Maillard reaction inhibitor |
-
2012
- 2012-12-27 AU AU2012361496A patent/AU2012361496A1/en not_active Abandoned
- 2012-12-27 IN IN5786DEN2014 patent/IN2014DN05786A/en unknown
- 2012-12-27 CN CN201280068032.4A patent/CN104114176A/en active Pending
- 2012-12-27 CA CA2861745A patent/CA2861745A1/en not_active Abandoned
- 2012-12-27 US US14/368,808 patent/US20140349953A1/en not_active Abandoned
- 2012-12-27 JP JP2013513895A patent/JP5441232B2/en not_active Expired - Fee Related
- 2012-12-27 BR BR112014015928A patent/BR112014015928A8/en not_active Application Discontinuation
- 2012-12-27 EP EP12863697.4A patent/EP2799075A4/en not_active Withdrawn
- 2012-12-27 KR KR1020147020814A patent/KR20140107614A/en not_active Application Discontinuation
- 2012-12-27 RU RU2014131057A patent/RU2014131057A/en unknown
- 2012-12-27 SG SG11201403628SA patent/SG11201403628SA/en unknown
- 2012-12-27 WO PCT/JP2012/083992 patent/WO2013100105A1/en active Application Filing
-
2013
- 2013-10-28 JP JP2013223611A patent/JP5538611B2/en not_active Expired - Fee Related
-
2014
- 2014-06-26 PH PH12014501485A patent/PH12014501485A1/en unknown
-
2015
- 2015-01-12 HK HK15100295.5A patent/HK1199823A1/en unknown
- 2015-08-20 US US14/830,835 patent/US20160058782A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20140349953A1 (en) | 2014-11-27 |
WO2013100105A1 (en) | 2013-07-04 |
SG11201403628SA (en) | 2014-10-30 |
JP2014028858A (en) | 2014-02-13 |
US20160058782A1 (en) | 2016-03-03 |
PH12014501485A1 (en) | 2014-09-22 |
JP5441232B2 (en) | 2014-03-12 |
BR112014015928A2 (en) | 2017-06-13 |
CN104114176A (en) | 2014-10-22 |
CA2861745A1 (en) | 2013-07-04 |
JP5538611B2 (en) | 2014-07-02 |
AU2012361496A1 (en) | 2014-07-24 |
JPWO2013100105A1 (en) | 2015-05-11 |
KR20140107614A (en) | 2014-09-04 |
HK1199823A1 (en) | 2015-07-24 |
RU2014131057A (en) | 2016-02-20 |
AU2012361496A2 (en) | 2014-07-24 |
EP2799075A4 (en) | 2015-07-15 |
EP2799075A1 (en) | 2014-11-05 |
BR112014015928A8 (en) | 2017-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2014DN05786A (en) | ||
MX355153B (en) | Active compound combinations comprising carboxamide derivatives and a biological control agent. | |
MX2013011835A (en) | Nutritional compositions including branched chain fatty acids for wound healing. | |
WO2012068357A4 (en) | Cosmetic compositions and methods for inhibiting or reducing trypsin activity based on cyclohexane- 1, 2, 3, 4, 5, 6 -hexol and a n-acyl amino acid compound | |
WO2012072713A3 (en) | Lysine demethylase inhibitors such as cyclylcyclopropanamine derivatives for use in the treatment of diseases and disorders associated with flaviviridae | |
MY165122A (en) | Dipeptidyl peptidase-iv (dppiv) inhibitory peptide compound, composition containing the same, and production method for the same | |
WO2013178965A3 (en) | Active ingredients activating mitophagy in skin cells and use of same for improving skin condition | |
WO2011126250A3 (en) | Composition containing pde5 inhibitor for relieving skin wrinkles | |
WO2011049327A3 (en) | A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof | |
WO2018093238A3 (en) | Composition comprising as active ingredient strain having excellent ability to produce formic acid for preventing or treating obesity or metabolic syndromes caused by obesity | |
WO2008070859A3 (en) | Treatment of skin conditions by dickkopf1 (dkk1) | |
WO2012104240A3 (en) | Cosmetic use | |
MY161419A (en) | Skin collagen production-promoting agent | |
PH12018501060A1 (en) | Composition for preventing or treating hair loss comprising chemokine (c-x-c motif) ligand 1 (cxcl1) protein | |
PH12017501200A1 (en) | A skin lightening composition comprising niacinamide and ilomastat | |
WO2012008788A3 (en) | Composition containing serine as an active ingredient for the prevention and treatment of fatty liver diseases, and use thereof | |
WO2013000895A9 (en) | Dha and epa in the reduction of oxidative stress | |
WO2014030117A3 (en) | Cosmetic use of the essential oil of laserpitium siler l. against the signs of aging of the skin and as a skin antioxidant | |
NZ596015A (en) | Method and composition for the treatment of pain and/or inflammation | |
WO2010126260A3 (en) | Pharmaceutical composition for promoting the healing of wounds and containing lysophosphatidic acid and an adenylyl cyclase inhibitor as active ingredients | |
EP3513799A4 (en) | Composition which contains lactic acid bacterium as effective component and which is for preventing or ameliorating skin condition deterioration caused by abnormal proliferation of specific bacterium in skin | |
MY162943A (en) | Sense-improving agent | |
WO2012122532A3 (en) | Compositions and methods for treatment of hyperuricemia | |
WO2011157609A3 (en) | Use of amino acid derivatives as agents for treating human perspiration, peptide derivatives, and compositions containing them | |
WO2010117241A3 (en) | Composition for prevention or treatment of hypertrophic scars or keloids |